Three Levels Face Centered Central Composite Design of Colon Targeted Micro-Particulates System of Celecoxib: Screening of Formulations Variables and in vivo Studies

ISSN: 1875-5704 (Online)
ISSN: 1567-2018 (Print)

Volume 14, 8 Issues, 2017

Download PDF Flyer

Current Drug Delivery

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Istvan Toth
School of Pharmacy,University of Queensland
Brisbane, 4072

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 1.446

Three Levels Face Centered Central Composite Design of Colon Targeted Micro-Particulates System of Celecoxib: Screening of Formulations Variables and in vivo Studies

Current Drug Delivery, 11(5): 621-635.

Author(s): Bankim Chandra Nandy, Vinod Verma, Sanjay Dey and Bhaskar Mazumder.

Affiliation: Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh-786004, Assam, India.


Celecoxib is a well known non-steroidal anti-inflammatory drug (NSAID) and extensively employed for the treatment of arthritis. The aim of the present study was to design, develop and optimization of micro particulates system, for colon specific delivery of celecoxib for both local (in prophylaxis of colorectal adreno-carcinoma) and systemic (in chrono-therapeutic treatment of arthritis) therapy. The aim of the present work was to elucidate the effect of formulation variables e.g., amount of eudragit polymer (X1), surfactant concentration (X2) and agitation speed (X3) on in-vitro release profiles (Y1-Y3), drug entrapment efficiency (Y4) and particle size (Y5) of micro-particulates system of celecoxib. Microspheres were formulated with the combination of ethyl cellulose (EC) and eudragit RS100/eudragit S100; by using a novel quasi emulsion solvent diffusion technique. Developed formulations were characterized and evaluated on the basis of FTIR, thermal, particle size, SEM and XRD analysis. The formulation variables were optimized by response surface methodology (RSM). Best optimized delayed release formulation was further subjected to the in vivo x-ray studies to evaluate the site specificity. It was found that in-vitro release (Y1-Y3 ) decreased significantly (p<0.05) with increase in amount of eudragit polymer but increased significantly (p<0.05) with an increase in surfactant concentration and stirring speed. FTIR study indicated that no strong chemical interaction took place between the drug and excipients of prepared formulations. DSC and XRD studies indicated that drug was present in the amorphous state. The X-ray photographs revealed that the swelling layer eroded from the outer surface and a size reduction was seen after 6 hrs when optimized microspheres reached the site of colon. Therefore, this approach suggested that the combination of eudragit S100 and ethyl cellulose microspheres may be useful for the delivery of maximum amount of celecoxib in intact form to the colon.


Celecoxib, Central composite-face centered design, Colon targeted delivery system, In vivo x-ray studies, Response Surface Methodology (RSM).

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 11
Issue Number: 5
First Page: 621
Last Page: 635
Page Count: 15
DOI: 10.2174/1567201811666140519161628
Price: $58
14th annual Controlled Release Delivery

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science